DOI:
10.1055/s-00022861
Aktuelle Kardiologie
LinksClose Window
References
Yusuf S, Teo KK, Pogue J et al.
Telmisartan, ramipril, or both in patients at high risk for vascular events.
N Engl J Med 2008;
358: 1547-1559
We do not assume any responsibility for the contents of the web pages of other providers.